Crosson FJ, Covinsky K, Redberg RF. Medicare and the Shocking US Food and Drug Administration Approval of Aducanumab: Crisis or Opportunity?. JAMA Intern Med. 2021 Oct 1;181(10):1278-1280. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

News

  1. Lecanemab Follows Aduhelm’s Path to Accelerated Approval